Interim Results of a Randomized Controlled Phase III Trial of Elective Nodal Irradiation Plus Erlotinib Combined with Chemotherapy for Esophageal Squamous Cell Carcinoma (Nct00686114)

Cell Carcinoma ◽

Squamous Cell ◽

Phase Iii ◽

Phase Iii Trial ◽

Elective Nodal Irradiation ◽

1435TiP Adjuvant immunotherapy for resected esophageal squamous cell carcinoma with high risk of recurrence (AIRES): A multicenter, open-label, randomized, controlled phase III trial

Annals of Oncology ◽

10.1016/j.annonc.2021.08.1544 ◽

2021 ◽

Vol 32 ◽

pp. S1072-S1073

Author(s):

X. Kang ◽

J. Xu ◽

R. Zhang ◽

Y. Song ◽

Z. Wang ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

High Risk ◽

Cell Carcinoma ◽

Squamous Cell ◽

Phase Iii ◽

Open Label ◽

Phase Iii Trial ◽

Adjuvant Immunotherapy ◽

166TiP Pembrolizumab combined with neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy followed surgery for locally advanced esophageal squamous cell carcinoma: Protocol for a multi-center, prospective, randomized-controlled, phase III clinical study (Keystone-002)

Annals of Oncology ◽

10.1016/j.annonc.2021.10.185 ◽

2021 ◽

Vol 32 ◽

pp. S1454-S1455

Author(s):

H. Jiang ◽

X. Shang ◽

C. Zhang ◽

J. Yue ◽

X. Duan ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Clinical Study ◽

Neoadjuvant Chemotherapy ◽

Cell Carcinoma ◽

Squamous Cell ◽

Locally Advanced ◽

Neoadjuvant Chemoradiotherapy ◽

Phase Iii ◽

Comparison between the effects of elective nodal irradiation and involved‐field irradiation on long‐term survival in thoracic esophageal squamous cell carcinoma patients: A prospective, multicenter, randomized, controlled study in China

Cancer Medicine ◽

10.1002/cam4.3409 ◽

2020 ◽

Vol 9 (20) ◽

pp. 7460-7468

Author(s):

Jiahua Lyu ◽

Abulimiti Yisikandaer ◽

Tao Li ◽

Xiaozhi Zhang ◽

Xiaohu Wang ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Squamous Cell ◽

Controlled Study ◽

Term Survival ◽

Elective Nodal Irradiation ◽

Randomized Controlled ◽

Involved Field

A single institutional phase III trial of preoperative chemotherapy with hyperfractionation radiotherapy plus surgery versus surgery alone for resectable esophageal squamous cell carcinoma

Annals of Oncology ◽

10.1093/annonc/mdh219 ◽

2004 ◽

Vol 15 (6) ◽

pp. 947-954 ◽

Cited By ~ 231

Author(s):

J.-L. Lee ◽

S.I. Park ◽

S.-B. Kim ◽

H.-Y. Jung ◽

G.H. Lee ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Preoperative Chemotherapy ◽

Squamous Cell ◽

Phase Iii ◽

Phase Iii Trial ◽

Resectable Esophageal

Postoperative Adjuvant therapy versus Surgery Alone for Stage IIB‐III Esophageal Squamous Cell Carcinoma: A Phase III Randomized Controlled Trial

The Oncologist ◽

10.1002/onco.13914 ◽

2021 ◽

Author(s):

Wenjie Ni ◽

Shufei Yu ◽

Zefen Xiao ◽

Zongmei Zhou ◽

Dongfu Chen ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Randomized Controlled Trial ◽

Adjuvant Therapy ◽

Cell Carcinoma ◽

Squamous Cell ◽

Controlled Trial ◽

Phase Iii ◽

Postoperative Adjuvant Therapy ◽

Postoperative Radiotherapy in Pathological T2–3N0M0 Thoracic Esophageal Squamous Cell Carcinoma: Interim Report of a Prospective, Phase III, Randomized Controlled Study

The Oncologist ◽

10.1634/theoncologist.2019-0276 ◽

2020 ◽

Vol 25 (4) ◽

Cited By ~ 3

Author(s):

Wei Deng ◽

Jinsong Yang ◽

Wenjie Ni ◽

Chen Li ◽

Xiao Chang ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Squamous Cell ◽

Postoperative Radiotherapy ◽

Phase Iii ◽

Controlled Study ◽

Interim Report ◽

Randomized Controlled ◽

Prospective Phase

Phase III randomized study of elective nodal irradiation plus erlotinib combined with chemotherapy for esophageal squamous cell carcinoma.

Journal of Clinical Oncology ◽

10.1200/jco.2016.34.15_suppl.4048 ◽

2016 ◽

Vol 34 (15_suppl) ◽

pp. 4048-4048

Author(s):

Shi Xiu Wu ◽

Honglei Luo ◽

Lvhua Wang ◽

Xuebang Zhang ◽

Bing Xia ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Squamous Cell ◽

Randomized Study ◽

Phase Iii ◽

Elective Nodal Irradiation

A Randomized Phase III Trial on the Role of Esophagectomy in Complete Responders to Preoperative Chemoradiotherapy for Esophageal Squamous Cell Carcinoma (ESOPRESSO)

Anticancer Research ◽

10.21873/anticanres.13707 ◽

2019 ◽

Vol 39 (9) ◽

pp. 5123-5133 ◽

Cited By ~ 2

Author(s):

SOOK RYUN PARK ◽

DOK HYUN YOON ◽

JONG HOON KIM ◽

YONG-HEE KIM ◽

HYEONG RYUL KIM ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Squamous Cell ◽

Preoperative Chemoradiotherapy ◽

Phase Iii ◽

Phase Iii Trial

Randomized Controlled Trial of Irinotecan Plus S-1 for Pretreated Patients with Advanced Esophageal Squamous Cell Carcinoma

SSRN Electronic Journal ◽

10.2139/ssrn.3235661 ◽

2018 ◽

Author(s):

Jing Huang ◽

Binghe Xu ◽

Ying Liu ◽

Junxing Huang ◽

Ping Lu ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Randomized Controlled Trial ◽

Cell Carcinoma ◽

Squamous Cell ◽

Controlled Trial ◽

Randomized Controlled ◽

Pretreated Patients

LUX-Lung 8 phase III trial: Analysis of long-term response to second-line afatinib in patients with advanced squamous cell carcinoma (SCC) of the lung

Annals of Oncology ◽

10.1093/annonc/mdx091.022 ◽

2017 ◽

Vol 28 ◽

pp. ii37 ◽

Cited By ~ 1

Author(s):

J.C.-H. Yang ◽

G. Goss ◽

E. Felip ◽

S. Lu ◽

A. Ardizzoni ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Squamous Cell ◽

Phase Iii ◽

Advanced Squamous Cell Carcinoma ◽

Second Line ◽

Phase Iii Trial ◽

Trial Analysis ◽

Term Response